Fate Therapeutics, Inc.
← Back to FATE Overview

Fate Therapeutics, Inc. (FATE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.15

Financial Fundamentals

FATEQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2012-09-30-3.60
2012-12-31-3.52
2013-03-31-4.14
2013-06-30-5.71
2013-09-30-5.17
2013-12-31-5.41
2014-03-31-7.16
2014-06-30-5.26
2014-09-30-3.98
2014-12-31-4.19
2015-03-31-3.22
2015-06-30-4.90
2015-09-30-5.55
2015-12-31-3.24
2016-03-31-1.55
2016-06-30-1.47
2016-09-30-2.89
2016-12-31-2.99
2017-03-31-4.74
2017-06-30-3.52
2017-09-30-3.81
2017-12-31-5.27
2018-03-31-9.04
2018-06-30-7.66
2018-09-30-13.10
2018-12-31-12.83
2019-03-31-14.63
2019-06-30-14.76
2019-09-30-9.71
2019-12-31-13.22
2020-03-31-12.62
2020-06-30-24.51
2020-09-30-14.69
2020-12-31-37.27
2021-03-31-42.94
2021-06-30-37.41
2021-09-30-32.93
2021-12-31-20.32
2022-03-31-16.43
2022-06-30-7.84
2022-09-30-6.75
2022-12-31-5.04
2023-03-31-15.24
2023-06-30-2.20
2023-09-30-1.15
2023-12-31-2.08
2024-03-31-3.77
2024-06-30-2.47
2024-09-30-2.19
2024-12-31-0.94
2025-03-31-0.62
2025-06-30-0.97
2025-09-30-1.17
2025-12-31-0.91
2026-03-31-1.15

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.